| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $6.55B | $6.23B | $6.18B |
| YoY Revenue Growth % | +5.2% | +0.8% | — |
| Gross Profit | $2.38B | $2.28B | — |
| Gross Margin % | 36.4% | 36.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $271.0M | $310.0M | $246.0M |
| Operating Margin % | 4.1% | 5.0% | 4.0% |
| Net Income (GAAP) | $161.0M | $165.0M | $109.0M |
| EBITDA (Normalized) | $420.6M | $452.4M | $468.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $499.0M | $425.0M | $389.0M |
| Capital Expenditures (CapEx) | $187.0M | $178.0M | $278.2M |
| Free Cash Flow (FCF) | $312.0M | $247.0M | $110.8M |
| FCF Margin % | 4.8% | 4.0% | 1.8% |
| Return on Invested Capital (ROIC %) | 16.4% | 17.7% | 4.3% |
| Cash & Short-Term Equivalents | $518.0M | $227.0M | — |
| Total Debt (Short + Long Term) | $971.0M | $973.0M | $1.74B |
| Total Stockholders' Equity | $856.0M | $640.0M | $3.56B |